ASX:GSS

Genetic Signatures (GSS) Stock Price, News & Analysis

→ Will this $2 AI stock double overnight? (From Behind the Markets) (Ad)

Free GSS Stock Alerts

Compare

Today's Range: N/A
50-Day Range: N/A
52-Week Range: N/A

Volume: N/A
Average Volume: N/A
Market Capitalization: N/A

P/E Ratio: N/A
Dividend Yield: N/A
Price Target: N/A

Stock Analysis

Get Genetic Signatures alerts:

Ad Stansberry Research

Strange new buyer driving up gold

One Wall Street trader just made a big new gold prediction: "Pay attention to physical demand for gold... the interest seen over the last week has been unprecedented."

But there's a much better move you can make to get in front of these big moves today.

About Genetic Signatures Stock (ASX:GSS)

Genetic Signatures Limited operates as a molecular diagnostic (MDx) company in Australia, the Asia Pacific, the Americas, Europe, the Middle East, Israel, and Africa. It designs and manufactures a suite of real-time polymerase chain reaction-based products for detection of infectious diseases under the EasyScreen brand name. The company also provides MDx 3Base platform technology that enables hospital and pathology laboratories to screen for a range of infectious pathogens. In addition, it offers detection kits for gastrointestinal infections, respiratory, sexual health, anti-microbial resistance, meningitis, and tropical disease. Genetic Signatures Limited was incorporated in 2001 and is headquartered in Newtown, Australia.

Ad Stansberry Research

Strange new buyer driving up gold

One Wall Street trader just made a big new gold prediction: "Pay attention to physical demand for gold... the interest seen over the last week has been unprecedented."

But there's a much better move you can make to get in front of these big moves today.

GSS Stock News Headlines

March 6, 2024 | msn.com

Genetic mutation in a quarter of all Labradors hard-wires them for obesity

February 6, 2024 | msn.com

Researchers at U of C reveal new kit making genetic mutation testing quick, accessible, affordable

April 19, 2024 | Stansberry Research (Ad)

Strange new buyer driving up gold

One Wall Street trader just made a big new gold prediction: "Pay attention to physical demand for gold... the interest seen over the last week has been unprecedented."

February 6, 2024 | msn.com

Researchers create a new tool to rapidly diagnose genetic mutations

January 13, 2024 | money.usnews.com

Genetic Counselor Salary

January 5, 2024 | morningstar.com

Genetic Signatures Ltd GSS

December 13, 2023 | bbc.com

How ancient DNA is transforming our view of the past

November 13, 2023 | bbc.co.uk

How is genetic information inherited? - OCR 21st Century

April 19, 2024 | Stansberry Research (Ad)

Strange new buyer driving up gold

One Wall Street trader just made a big new gold prediction: "Pay attention to physical demand for gold... the interest seen over the last week has been unprecedented."

October 16, 2023 | msn.com

Genetic science is the future of food security – Olam Agri Brands Mgr

September 22, 2023 | finance.yahoo.com

Calculating The Intrinsic Value Of Genetic Signatures Limited (ASX:GSS)

September 4, 2023 | msn.com

ASX Health Stocks: Genetic Signatures jumps 20pc on FDA update, Proteomics reveals new patent in Japan

August 14, 2023 | cbsnews.com

Genetic genealogist helps solve a case that had "a gnat's eyebrow of DNA" left from the crime scene

June 13, 2023 | abcnews.go.com

Lawyer arrested in over decade-old rapes after being identified by genetic genealogy

May 3, 2023 | nj.com

How DNA and genetic genealogy are solving decades-old cold cases | The Unidentifieds podcast: Ep. 3

April 15, 2023 | msn.com

Genetic signature discovery may revolutionise liver cancer diagnosis and monitoring

April 12, 2023 | omaha.com

Germline Genetic Testing Feasible for Advanced Prostate Cancer

April 6, 2023 | bbc.co.uk

Potential benefits and risks of genetic engineering

March 31, 2023 | nytimes.com

DNA Confirms Oral History of Swahili People

March 15, 2023 | msn.com

MoneyTalks: Zip share price could quadruple while Genetic Signatures to triple, say these brokers

March 3, 2023 | msn.com

Unknown lineage of ice age Europeans discovered in genetic study

January 18, 2023 | uk.news.yahoo.com

Those who invested in Genetic Signatures (ASX:GSS) five years ago are up 210%

January 11, 2023 | foxnews.com

Massachusetts woman murdered more than 50 years ago identified by authorities using genetic genealogy

December 11, 2022 | marketwatch.com

Genome Editing Market Dynamics with Top Players, Gross Margin, Regional Demand, Plans and Demand Status Forecast to 2028

November 3, 2022 | cnbc.com

These dads drove over 57 hours, livestreamed the cross-country trip on YouTube and raised $156,000 for their kids’ rare genetic disease

October 12, 2022 | nz.finance.yahoo.com

Are Genetic Signatures Limited's (ASX:GSS) Fundamentals Good Enough to Warrant Buying Given The Stock's Recent Weakness?

September 2, 2022 | investing.com

Genetic Signatures Ltd (GSS)

See More Headlines

Receive GSS Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Genetic Signatures and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Stock Exchange: ASX
Sector: Medical
Industry: Diagnostics & Research
Sub-Industry: N/A
Current Symbol: ASX:GSS
CUSIP: N/A
CIK: N/A
Web: www.geneticsignatures.com
Phone: 61 2 9870 7580
Fax: N/A
Employees: 1,626
Year Founded: N/A

Profitability

EPS (Most Recent Fiscal Year): A($0.12)
Trailing P/E Ratio: N/A
Forward P/E Ratio: N/A
P/E Growth: N/A
Net Income: $-18,040,000.00
Net Margins: -112.83%
Pretax Margin: N/A
Return on Equity: -40.28%
Return on Assets: -23.50%

Debt

Debt-to-Equity Ratio: 0.03
Current Ratio: 8.06
Quick Ratio: 8.54

Sales & Book Value

Annual Sales: $15.99 million
Price / Sales: 0.00
Cash Flow: N/A
Price / Cash Flow: N/A
Book Value: A$0.28 per share
Price / Book: N/A

Miscellaneous

Outstanding Shares: 186,480,000
Free Float: N/A
Market Cap: N/A
Optionable: Not Optionable
Beta: 0.12

These 7 Stocks Will Be Magnificent in 2024

With average gains of 150% since the start of 2023, now is the time to give these stocks a look and pump up your 2024 portfolio.

Get This Free Report

Key Executives

Dr. John R. Melki BSc
Ph.D., MD, CEO & Executive Director
Mr. Michael Anton Aicher BSc (Age 64)
M.B.A., MBA, Executive Director of US Operations & Executive Director
Comp: $178.42k
Mr. Christopher M. Abbott
Founder & Chairman Emeritus
Mr. Karl David Pechmann
CFO, COO & Company Secretary
Dr. Douglas S. Millar BSc
Ph.D., Chief Scientific Officer
Ms. Rebecca Abbatantuono
Global Head of People & Culture
Ms. Neralie Coulston B.Sc.
Global Head of Regulatory Affairs
Mr. Jackson Jones B.Sc.
Chief Commercial Officer

Key Competitors

View All Competitors

Insiders

This page (ASX:GSS) was last updated on 4/19/2024 by MarketBeat.com Staff

From Our Partners

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial

Genetic Signatures (GSS) Stock Price, News & Analysis

About Genetic Signatures Stock (ASX:GSS)

GSS Stock News Headlines

Industry, Sector and Symbol

Profitability

Debt

Sales & Book Value

Miscellaneous

Key Executives

Key Competitors

Insiders

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info